ron tilles

Pharma

Martin Shkreli resigns Turing; new interim CEO appointed

Ron Tilles, the chairman of the board for Turing Pharmaceuticals, has stepped up to replace Martin Shkreli as CEO.

Why Your Patients Are Leaving and How to Stop It

Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.

By Bryan Sequeira, Director, Product Management Greenway Health

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News